Trust Co. of Vermont acquired a new stake in shares of Cardinal Health, Inc. (NYSE:CAH – Free Report) in the second quarter, HoldingsChannel.com reports. The fund acquired 4,206 shares of the company’s stock, valued at approximately $999,000.
Other hedge funds also recently made changes to their positions in the company. University of Texas Texas AM Investment Management Co. bought a new stake in Cardinal Health in the 4th quarter worth $26,000. Bank of Jackson Hole Trust purchased a new position in shares of Cardinal Health in the fourth quarter valued at about $27,000. Jones Financial Companies Lllp raised its stake in shares of Cardinal Health by 198.3% during the first quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock valued at $27,000 after acquiring an additional 14,034 shares during the last quarter. Palladiem LLC purchased a new stake in shares of Cardinal Health during the fourth quarter worth about $28,000. Finally, Indiana Trust & Investment Management Co purchased a new stake in shares of Cardinal Health during the first quarter worth about $29,000. 87.17% of the stock is owned by hedge funds and other institutional investors.
Cardinal Health Stock Performance
Shares of NYSE CAH opened at $234.85 on Wednesday. The company has a 50 day simple moving average of $231.38 and a two-hundred day simple moving average of $217.51. Cardinal Health, Inc. has a fifty-two week low of $145.87 and a fifty-two week high of $258.30. The company has a market capitalization of $54.62 billion, a price-to-earnings ratio of 32.48, a P/E/G ratio of 1.26 and a beta of 0.49.
Cardinal Health Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Thursday, October 15th. Stockholders of record on Thursday, October 1st will be issued a dividend of $0.5158 per share. The ex-dividend date is Thursday, October 1st. This represents a $2.06 dividend on an annualized basis and a dividend yield of 0.9%. Cardinal Health’s dividend payout ratio is presently 28.49%.
Analysts Set New Price Targets
Several analysts recently weighed in on the stock. William Blair started coverage on shares of Cardinal Health in a report on Tuesday, April 28th. They issued an “outperform” rating on the stock. JPMorgan Chase & Co. lifted their target price on shares of Cardinal Health from $215.00 to $260.00 and gave the company a “neutral” rating in a research note on Thursday, August 13th. Barclays boosted their price target on shares of Cardinal Health from $258.00 to $275.00 and gave the company an “overweight” rating in a research report on Thursday, August 13th. Wall Street Zen raised shares of Cardinal Health from a “buy” rating to a “strong-buy” rating in a research note on Saturday, July 4th. Finally, Wells Fargo & Company increased their price objective on Cardinal Health from $245.00 to $277.00 and gave the stock an “overweight” rating in a report on Wednesday, August 12th. Sixteen research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat, Cardinal Health currently has a consensus rating of “Moderate Buy” and an average price target of $265.93.
Check Out Our Latest Report on CAH
Cardinal Health Profile
Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.
The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.
See Also
- Five stocks we like better than Cardinal Health
- The AI Boom Is Turning This Cable Maker Into a Stock to Watch
- A Star Investor Just Trimmed Amazon—Here’s What It means
- Wendy’s Deal Buzz May Give Fast-Food Investors a New Reason to Look
- Home Depot Analysts See a Path to $375 and Beyond
Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH – Free Report).
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.
